Biopharmaceutical company Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, reported Thursday that first-quarter net income attributable to the company declined 35 percent to $2.82 billion or $1.11 per share from $4.31 billion or $1.70 per share in the prior-year quarter.
from RTT - Earnings https://ift.tt/H318fIl
via IFTTT
No comments:
Post a Comment